PHARMACOVIGILANCE ON HERBAL MEDICINES IN A BRAZILIAN PHARMACEUTICAL INDUSTRY: MECHANISM FOR PRODUCTS IMPROVEMENT

Authors

  • Fabiane Sobrinho de Abreu Universidade Estácio de Sá Rua do Bispo, 83 - Bloco AG, Lab 12 20261-063 - Rio de Janeiro RJ Brasil
  • Regina Braga de Moura Universidade Estácio de Sá Rua do Bispo, 83 - Bloco AG, Lab 12 20261-063 - Rio de Janeiro RJ Brasil

DOI:

https://doi.org/10.14450/2318-9312.v26.e3.a2014.pp149-156

Keywords:

phytotherapy, adverse events, herbal medicine

Abstract

The use of herbal medicines is based on popular traditions and considered a therapeutic alternative to the use of official medicine. Incorrectly, the use of these medications is considered as exempt from adverse reactions. However, it may cause harmful effects if used with no proper guidance. After been released in the market, drugs may cause unexpected adverse reactions, making necessary pharmacovigilance work. This study aimed to investigate cases of adverse reactions registered for herbal medicines from a Brazilian pharmaceutical industry. Therefore, a descriptive, retrospective, cross-sectional and quantitative study was carried out for a period of eighteen months, through a database of spontaneous reports of unexpected events for herbal medicinnes produced by the mentioned industry. During the evaluation period, thirty-two notifications were registered, distributed among six herbal medicines containing: Trifolium pratense L, Pinus pinaster Aiton, Hedera helix L., Tribullus terrestris L., Pelargonium sidoides DC., Cimicifuga racemosa (L.) Nutt. The most reported adverse reaction, regardless of plant species, was allergy. People above fifty years old were responsible for most reports, originated mainly from Brazilian southeastern region. It was possible to conclude that most herbal medicines produced and distributed by the pharmaceutical laboratory involved in this study can be considered safe and effective for the treatment of diseases which they are designed to. In order to guarantee better contact between the notifier and the prescriber, it is important to disclose pharmacovigilance of herbal medicines among health workers. In this sense, it is possible to know the probable harmful effects, allowing actions to improve the product, ensuring its efficacy and safety.

Author Biographies

Fabiane Sobrinho de Abreu, Universidade Estácio de Sá Rua do Bispo, 83 - Bloco AG, Lab 12 20261-063 - Rio de Janeiro RJ Brasil

Farmacêutica com experiência em farmacovigilância de fitoterápicos

Regina Braga de Moura, Universidade Estácio de Sá Rua do Bispo, 83 - Bloco AG, Lab 12 20261-063 - Rio de Janeiro RJ Brasil

Professora Titular e Pesquisadora do Curso de Farmácia

Downloads

Published

2014-09-17

How to Cite

Abreu, F. S. de, & Moura, R. B. de. (2014). PHARMACOVIGILANCE ON HERBAL MEDICINES IN A BRAZILIAN PHARMACEUTICAL INDUSTRY: MECHANISM FOR PRODUCTS IMPROVEMENT. Infarma - Pharmaceutical Sciences, 26(3), 149–156. https://doi.org/10.14450/2318-9312.v26.e3.a2014.pp149-156

Issue

Vol. 26 No. 3 (2014)

Section

Original article

License

Authors who publish in this journal agree to the following terms:

 

  1. Authors retain the copyright and grant the journal the right of first publication, with the work simultaneously licensed under the Licença Creative Commons Attribution which allows the sharing of work with acknowledgment of authorship and initial publication in this journal.
  2. Authors are authorized to take additional contracts separately, for non-exclusive distribution of the version of the work published in this journal (e.g. publish in institutional repository or as a book chapter), with acknowledgment of authorship and initial publication in this journal.
  3. Authors are allowed and encouraged to publish and distribute their work online (e.g. in institutional repositories or on their personal page) at any point before or during the editorial process, as this can generate productive changes as well as increase the impact and Citation of published work (See O Efeito do Acesso Livre ).